Compare CNMD & BUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNMD | BUR |
|---|---|---|
| Founded | 1970 | 2009 |
| Country | United States | Guernsey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 985.5M | 814.7M |
| IPO Year | 1995 | 2017 |
| Metric | CNMD | BUR |
|---|---|---|
| Price | $51.12 | $3.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $46.83 | $8.49 |
| AVG Volume (30 Days) | 387.4K | ★ 2.6M |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 3.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.87 | N/A |
| Revenue | ★ $1,374,724,000.00 | $413,360,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.73 | N/A |
| P/E Ratio | $27.49 | ★ N/A |
| Revenue Growth | ★ 5.18 | N/A |
| 52 Week Low | $31.44 | $2.86 |
| 52 Week High | $54.80 | $10.10 |
| Indicator | CNMD | BUR |
|---|---|---|
| Relative Strength Index (RSI) | 58.28 | 50.94 |
| Support Level | $43.95 | $3.58 |
| Resistance Level | $53.09 | $4.52 |
| Average True Range (ATR) | 2.29 | 0.20 |
| MACD | 0.45 | 0.04 |
| Stochastic Oscillator | 66.02 | 39.08 |
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
Burford Capital Ltd provides capital against the underlying value of litigation and legal assets, known as legal finance, serving the legal industry with financial products and services. Its business is funding clients engaged in ongoing legal disputes to pay legal fees and monetize the expected future value of disputes, focusing on large, complex matters. The company has two reportable segments: Principal Finance, which earns maximum revenue and allocates capital to legal finance assets from its balance sheet and through interests in private funds managed by the company, and Asset Management and Other Services, which manages legal finance assets for third-party investors and provides other services to the legal industry.